Risk of Ocular Adverse Events Associated With Use of Phosphodiesterase 5 Inhibitors in Men in the US-Reference-Cited by-同舟云学术

Risk of Ocular Adverse Events Associated With Use of Phosphodiesterase 5 Inhibitors in Men in the US

Published:2022-05-01 Issue:5 Volume:140 Page:480
ISSN:2168-6165
Container-title:JAMA Ophthalmology
language:en
Short-container-title:JAMA Ophthalmol

Author:

Etminan Mahyar¹²³,Sodhi Mohit¹⁴,Mikelberg Frederick S.¹,Maberley David¹⁵

Affiliation:

1. Collaboration for Epidemiology of Ocular Diseases (CEPOD), Department of Ophthalmology and Visual Sciences, Faculty of Medicine, University of British Columbia, Vancouver, British Columbia, Canada

2. Department of Anesthesiology, Pharmacology, and Therapeutics, Faculty of Medicine, University of British Columbia, Vancouver, British Columbia, Canada

3. Division of Neurology, Department of Medicine, University of British Columbia, Vancouver, British Columbia, Canada

4. Faculty of Medicine, University of British Columbia, Vancouver, British Columbia, Canada

5. Department of Ophthalmology, Faculty of Medicine, University of Ottawa, Ottawa, Ontario, Canada

Publisher

American Medical Association (AMA)

Subject

Ophthalmology

Link

https://jamanetwork.com/journals/jamaophthalmology/articlepdf/2790661/jamaophthalmology_etminan_2022_oi_220014_1651869686.78153.pdf

Reference17 articles.

1. Food and Drug Administration adverse event reports of retinal vascular occlusions associated with phosphodiesterase type 5 inhibitor use.;Li;J Neuroophthalmol,2016

2. Ischemic optic neuropathy in male veterans prescribed phosphodiesterase-5 inhibitors.;Margo;Am J Ophthalmol,2007

3. Association between phosphodiesterase-5 inhibitors and nonarteritic anterior ischemic optic neuropathy.;Nathoo;J Neuroophthalmol,2015

4. Acute nonarteritic anterior ischemic optic neuropathy and exposure to phosphodiesterase type 5 inhibitors.;Campbell;J Sex Med,2015

5. Phosphodiesterase inhibitors and the eye.;Kerr;Clin Exp Ophthalmol,2009

Cited by 20 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Central serous chorioretinopathy: An evidence-based treatment guideline;Progress in Retinal and Eye Research;2024-07

2. Proceedings of PRINCETON IV: PDE5 inhibitors and cardiac health symposium;Sexual Medicine Reviews;2024-06-27

3. Changes in Posterior Ocular Structures in Individuals Using Phosphodiesterase 5 Inhibitor;Current Eye Research;2024-06-10

4. Nonarteritic Anterior Ischemic Optic Neuropathy After Recreational PDE5 Inhibitor Use in a Healthy Patient: More Evidence for Causation;Journal of Neuro-Ophthalmology;2024-04-19

5. Trends in psychogenic erectile dysfunction research: a bibliometric and visualized study;Journal of Men's Health;2024